Literature DB >> 20338616

Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases.

Nora Katabi1, Daniel Gomez, David S Klimstra, Diane L Carlson, Nancy Lee, Ronald Ghossein.   

Abstract

Carcinoma ex pleomorphic adenoma is a rare salivary gland neoplasm, especially when the malignant component is only intracapsular/minimally invasive. Moreover, only few studies have assessed the behavior of carcinoma ex pleomorphic adenoma according to the histologic subtype. Forty-three cases of carcinoma ex pleomorphic adenoma were identified over a 27-year period and subjected to a detailed histopathologic analysis. There were 13 intracapsular/minimally invasive and 30 widely invasive carcinomas. There were 15 myoepithelial carcinomas, 25 salivary duct carcinomas, 2 adenocarcinomas not otherwise specified, and 1 carcinosarcoma. There was a trend toward a higher frequency of myoepithelial carcinomas in widely invasive tumors (13/30, 43%) than in intracapsular/minimally invasive (2/13, 15%) carcinoma ex pleomorphic adenoma (P = .095). Adequate follow-up was available for 38 patients. Vascular invasion and distant metastases correlated with decreased disease-free survival and disease-specific survival (P < .05), whereas the extent of invasion and the presence of a high mitotic rate or atypical mitoses correlated with decreased disease-free survival only (P < .05). There was a trend toward worse disease-free survival and disease-specific survival in patients with myoepithelial carcinoma (P = .08). Within the intracapsular/minimally invasive carcinoma ex pleomorphic adenoma group, both myoepithelial carcinoma (2/2, 100%) had metastatic disease, whereas only 1 of 11 nonmyoepithelial carcinoma relapsed (P = .038). Vascular invasion, high mitotic rate, and histologic subtype were found to correlate with recurrence in carcinoma ex pleomorphic adenoma. Patients with intracapsular/minimally invasive tumor have a more favorable outcome than patients with widely invasive neoplasm, but intracapsular/minimally invasive carcinoma ex pleomorphic adenoma can recur and cause death. The presence of myoepithelial carcinoma subtype increases the risk of recurrence in carcinoma ex pleomorphic adenoma, especially within the group of intracapsular/minimally invasive tumors. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20338616     DOI: 10.1016/j.humpath.2009.12.011

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  24 in total

1.  Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.

Authors:  Nora Katabi; Ronald Ghossein; Alan Ho; Snjezana Dogan; Lei Zhang; Yun-Shao Sung; Cristina R Antonescu
Journal:  Hum Pathol       Date:  2014-09-07       Impact factor: 3.466

2.  Prognostic factors in myoepithelial carcinoma of salivary glands: a clinicopathologic study of 48 cases.

Authors:  Max Kong; Esther N Drill; Luc Morris; Lyndsay West; David Klimstra; Mithat Gonen; Ronald Ghossein; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2015-07       Impact factor: 6.394

3.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.

Authors:  Raja R Seethala; Göran Stenman
Journal:  Head Neck Pathol       Date:  2017-02-28

4.  Clinicopathological characteristics and cell cycle proteins as potential prognostic factors in myoepithelial carcinoma of salivary glands.

Authors:  F Passador-Santos; M Grönroos; J Irish; R Gilbert; P Gullane; B Perez-Ordonez; A Mäkitie; I Leivo
Journal:  Virchows Arch       Date:  2015-12-28       Impact factor: 4.064

5.  Disseminated carcinoma ex pleomorphic adenoma in an adolescent confirmed by application of PLAG1 immunohistochemistry and FISH for PLAG1 rearrangement.

Authors:  Armita Bahrami; James D Dalton; Shivakumar Bangalore; Charlene Henry; Jeffrey F Krane; Fariba Navid; David W Ellison
Journal:  Head Neck Pathol       Date:  2012-09

6.  A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements.

Authors:  Albert J H Suurmeijer; Brendan C Dickson; David Swanson; Lei Zhang; Yun-Shao Sung; Christopher D Fletcher; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2020-02-07       Impact factor: 5.006

Review 7.  Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.

Authors:  Silvana Di Palma
Journal:  Head Neck Pathol       Date:  2013-07-03

8.  Histological, immunohistological and molecular characteristics of intraductal precursor of carcinoma ex pleomorphic adenoma support a multistep carcinogenic process.

Authors:  Stephan Ihrler; Orlando Guntinas-Lichius; Abbas Agaimy; Agnes Wolf; Martin Mollenhauer
Journal:  Virchows Arch       Date:  2017-03-28       Impact factor: 4.064

9.  Carcinosarcoma ex non-recurrent pleomorphic adenoma composed of TTF-1 positive large cell neuroendocrine carcinoma and myofibrosarcoma: apropos a rare Case.

Authors:  Fredrik Petersson; Kwok Seng Loh
Journal:  Head Neck Pathol       Date:  2012-07-31

10.  Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma.

Authors:  Miguel Rito; Isabel Fonseca
Journal:  Virchows Arch       Date:  2015-12-05       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.